Cinctive Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Cinctive Capital Management’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$1.89M	Sell
2024 Q3	$2.53M	Buy
2022 Q3	–	Sell
2022 Q2	$560K	Buy